It can be concluded that the follicular phase GnRH protocol may be an option for PCOS patients with lower AMH levels and lower bLH/FSH levels, especially for patients with a history of poor clinical outcomes. This evidence concerns the gene GNRH1 and polycystic ovary syndrome.